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mAbstract
Background: The study of microglia and macrophage (M/M) morphology represents
a key tool to understand the functional activation state and the pattern of distribution
of these cells in acute brain injury. The identification of reliable quantitative
morphological parameters is urgently needed to understand these cell roles in
brain injury and to explore strategies aimed at therapeutically manipulating the
inflammatory response.
Methods: We used three different clinically relevant murine models of focal injury,
namely, controlled cortical impact brain injury (traumatic brain injury (TBI)) and
transient and permanent occlusion of middle cerebral artery (tMCAo and pMCAo,
respectively). Twenty-four hours after injury, M/M cells were labeled by CD11b,
and ×40 photomicrographs were acquired by unbiased sampling of the lesion core
using a motorized stage microscope. Images were processed with Fiji software to
obtain shape descriptors.
Results: We validated several parameters, including area, perimeter, Feret’s diameter
(caliper), circularity, aspect ratio, and solidity, providing quantitative information on
M/M morphology over wide tissue portions. We showed that the shape descriptors
that best represent M/M ramification/elongation are area and perimeter, while
circularity and solidity provide information on the ameboid shape. We also provide
evidence of the involvement of different populations in local inflammatory events,
with macrophages replacing microglia into the lesion core when reperfusion does
not occur. Analysis of CD45high+ cell morphology, whose shape does not change,
did not yield any difference, thus confirming the reliability of the approach.
Conclusions: We have defined specific morphological features that M/M acquire in
response to different acute insults by applying a sensitive and readily applicable
approach to cell morphological analysis in the brain tissue. Potential application of
this method can be extended to all cell types able to change shape following
activation, e.g., astrocytes, or to different disease states, including chronic pathologies.
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Microglia and macrophages are major cellular contributors to post-injury inflammatory
response in the brain. After acute injury, rapid activation with dramatic morphological
and phenotypical changes of the resident microglial cells as well as recruitment of blood-
borne macrophages occurs. In the unchallenged brain, microglia constantly survey the
microenvironment by extending and protruding thin branched processes [1]. After an2015 Zanier et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly credited.
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with enlarged soma and retracted processes [2]. These morphological changes are related
to the expression of novel surface antigens and to the production of mediators that build
up and maintain the inflammatory response or promote injury resolution and lesion re-
pair [3]. At variance with microglia, infiltrated macrophages undergo only minor morpho-
logical changes during recruitment and activation [4]. Similarly to microglia, depending
on the injured microenvironment, macrophages express novel/specific antigens and medi-
ators that define their polarization state and their function [5]. It is likely that the kind of
injury and its temporal and spatial evolution can drive selective microglia and macrophage
activation. These cells share common myeloid origin and are often referred to as a unique
population (microglia and macrophage (M/M)). It is not fully understood whether they
can acquire distinct functions in the context of brain injury. Microglia and macrophages
infiltrated in the injured brain are antigenically indistinguishable, and assessment of their
specific function is feasible only by irradiation chimerism or parabiosis techniques [6,7].
A deeper knowledge of the M/M characteristics in relation to the nature of the brain in-
sult and to the time and location relative to the lesion area is needed to properly manipu-
late the inflammatory response to promote a protective environment for therapeutical
purposes [8-10]. Many aspects of M/M behavior in response to different metabolic chal-
lenges still need clarification. Notably, morphological features provide information on the
functional commitment of M/M [11-13]. The ability to obtain a morphological descrip-
tion that may increase the insight on M/M functional meaning in brain pathology is thus
a priority. M/M activation is usually measured, assessing the expression of specific M/M
markers (CD11b, Iba1, F4/80) by immunohistochemistry [14]. This approach, however,
does not take into consideration morphological changes that could unravel specific M/M
functions after brain damage. Actin polymerization, leading to microglia shape transfor-
mations, has been demonstrated to be an ATP-dependent process [15,16]. This is at vari-
ance with what happens in macrophages that are better equipped to maintain the
functionality in hypoxic/ischemic conditions [17]. Microglia are, therefore, finely tuned by
the injured microenvironment that affects their shape while macrophages are character-
ized by their constant round-shaped morphology regardless of their tissue location.
In the present study, we provide a detailed analysis of a few morphological parame-
ters related to M/M activation in three murine models of focal acute brain injury mod-
eling traumatic brain injury (TBI) or stroke. Controlled cortical impact brain injury for
TBI and transient or permanent occlusion of middle cerebral artery (tMCAo and
pMCAo, respectively) for stroke are well established, clinically relevant models showing
important functional and metabolic correlates to human pathology. A comparison of
M/M morphology in the three models, each of which is characterized by different de-
grees of blood perfusion impairment, provides the opportunity to study M/M in differ-
ent pathological scenarios, thus leading to the definition of shape descriptors that best
represent the changes in M/M activation in local inflammatory events.Methods
Animals
C57BL/6J wt and cx3cr1+/GFP mice (Harlan Laboratories and Charles River, Italy) were
housed in a specific pathogen-free (SPF) vivarium. Procedures involving animals and
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pliance with national and international laws and policies [18]. They were reviewed and
approved by the Mario Negri Institute Animal Care and Use Committee that includes
ad hoc members for ethical issues and by the Italian Ministry of Health.
Surgery protocols
Transient middle cerebral artery occlusion
Anesthesia was induced by 3% isoflurane inhalation in an N2O/O2 (70%/30%) mixture and
maintained by 1% to 1.5% isoflurane inhalation in an N2O/O2 (70%/30%) mixture. Transient
ischemia was induced by means of a siliconized filament (7-0, Doccol Corp, Redlands, CA)
introduced into the right carotid artery, pushed onwards till the origin of the middle cerebral
artery (MCA) and withdrawn after a 30-min ischemic period [18]. Mortality rate was 8.3%.
Permanent middle cerebral artery occlusion
Mice were anesthetized with 100 μl/mouse Equitensin (pentobarbital 39 mM, chloral
hydrate 256 mM, MgSO4 86 mM, ethanol 10% v/v, propylenglycol 39.6% v/v) adminis-
tered by intraperitoneal (i.p.) injection. A vertical midline incision was made between
the right orbit and tragus. The temporal muscle was excised, and the right MCA was
exposed through a small burr hole in the temporal bone. The dura mater was cut with
a fine needle and the MCA permanently occluded by electrocoagulation just proximal
to the origin of the olfactory branch [19]. Intraoperative rectal temperature was kept at
37.0°C ± 0.5°C using a heating pad (LSI Letica). Mortality rate was 8.5%.
Experimental traumatic brain injury
Mice were anesthetized with 65 mg/kg sodium pentobarbital i.p. and placed in a stereo-
taxic frame. They were subjected to craniectomy followed by induction of TBI by con-
trolled cortical impact [20]. This model uses a 3-mm rigid impactor driven by a
pneumatic piston, rigidly mounted at an angle of 20° from the vertical plane and
applied perpendicularly to the exposed dura mater over the left parietotemporal cortex
at a velocity of 5 m/s and depth of 1 mm. The craniotomy was then covered with a cra-
nioplasty and the scalp sutured. During all surgical procedures, mice were maintained
at the body temperature of 37°C. No animals died after surgery.
Control mice did not receive any surgical intervention.
Histological analysis
Twenty-four hours after surgery, mice from each group were deeply anesthetized with Equi-
tensin (120 μl/mouse i.p.) and transcardially perfused with 30 ml of phosphate buffer saline
(PBS), 0.1 mol/l, pH 7.4, followed by 60 ml of chilled paraformaldehyde (4%) in PBS. After
carefully removing the brains from the skull, they were transferred to 30% sucrose in PBS at
4°C overnight for cryoprotection. The brains were then rapidly frozen by immersion in
isopentane at −45°C for 3 min before being sealed into vials and stored at −70°C until use.
Lesion size determination
Twenty-micrometer coronal brain cryosections were cut serially so to have sections dis-
tanced by ≈1 mm and stained with cresyl violet [21]. Seven slices from the bregma +2 mm
to −3.76 mm were evaluated. For ischemic lesion size determination, on each slice, the
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staining tracing the area on a video screen. The infarcted area and the percentage of brain
swelling for edema correction were determined by subtracting the area of the healthy tis-
sue in the ipsilateral hemisphere from that of the contralateral hemisphere on each sec-
tion [22,23]. Infarct volumes for each brain slice were quantified with computer-assisted
image analyzer and calculated by Analytical Image System (Imaging Research Inc., Brock
University, St. Catharines, Ontario, Canada).
For TBI contusion volume assessment, the ipsilateral and contralateral hemi-
spheres were manually outlined. Subsequently, the injured area was calculated by
subtracting the ipsilateral from the contralateral hemisphere. Finally, the contusion
volume was calculated by integrating the injured area according to the previously
reported formula [24].Immunohistochemistry
Immunohistochemistry was performed on 20-μm brain coronal sections using anti-
mouse CD11b (1:800, kindly provided by Dr. Doni, [21]) and biotinylated anti-mouse
CD45 (1:800, BD Biosciences Pharmigen, San Jose, CA). Positive cells were stained by
reaction with 3,3 diaminobenzidine tetrahydrochloride (DAB, Vector laboratories, CA,
USA). For negative control staining, the primary antibodies were omitted, and no stain-
ing was observed. CD45-positive cells displayed two morphologies [18]: a) leukocyte-
like shape corresponding to cells with a rounded cell body without branches and high
expression of CD45 (CD45high) and b) microglia-like shape having a small cell body
and several branches and a fainter expression of CD45 (CD45low, [18]). Quantification
was carried out only on CD45high rounded positive cells.Slice selection and quantitative analysis
Marker quantification for each model was carried out over one brain coronal section
per mouse at the stereotaxic coordinate showing the wider lesioned area (Figure 1A).
For each model, the ischemic core was selected for quantification as follows: 1) striatum
(at −0.9 mm from the bregma) that is fed by the MCA and shows the highest degree of
tissue damage after its occlusion (ischemic core, [21,25]) for tMCAo; 2) cortex at 0 mm,
the brain region including the ischemic core in the territory fed by the occluded branch of
the MCA [19,25] for pMCAo; and 3) cortex at −1.8 mm from the bregma, where contu-
sion edge was present (lesion core, [8]) for TBI. A drawing showing the field positioning
for quantification of immunostainings within selected brain regions is depicted in
Figure 1B (coordinate reference from [26]).
Field selection was performed using a BX61 Olympus microscope equipped with a
motorized stage, acquiring the focal plane corresponding to image maximal sharpness
(best focus) as calculated by the acquisition software AnalySIS (Olympus) [19]. Ten (for
tMCAo and pMCAo) or nine (for TBI) quantification fields at ×40 magnification (pixel
size = 0.172 μm) were uniformly distributed over the region of interest. Centers of
frames at ×40 were distanced 532 μm (tMCAo and pMCAo) or 358 μm (TBI) for hori-
zontally aligned frames and 266 μm for vertically aligned frames. The gap between
subsequent frames was chosen to avoid overlapping acquisitions (frame centers were
Figure 1 Lesion characteristics at 24 h after tMCAo, pMCAo, or TBI and placement of acquisition
fields. Lesion size distribution is shown at different anteroposterior (AP) coordinates relative to the bregma
for tMCAo, pMCAo, or TBI (n = 6) (A). The maximum lesion size for tMCAo is at −0.88 mm from the bregma,
for pMCAo at +0.08 mm, and for TBI at −1.84 mm from the bregma. For each injury model, representative
sections stained by cresyl violet are shown. The lesion has been sampled by distributing ×40 acquisition
fields over the region of interest as depicted in the figure (B) (scale bar = 1 mm). The frame centers at ×40
were distanced 532 μm (tMCAo and pMCAo) or 358 μm (TBI) for horizontally aligned frames and 266 μm
for vertically aligned frames, covering 0.2 mm2 total area. For tMCAo and pMCAo, acquisition fields were
placed within the lesion core, while for TBI, since part of the lesion core tissue is lost, acquisition fields were
positioned at the contusion edge.
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ing twice in consecutive frames.Image processing and quantification
Image processing was performed using Fiji software [27]. An algorithm was created to
segmentate and analyze stained cells. Briefly, images were first scaled into microns.
Background was subtracted, and a math operation was applied so that all the gray
values greater than a specified constant were replaced by the constant. The constant
was defined by the operator on the basis of the best segmentation performance on pilot
images and did not change across the experimental groups. Images were then binarized
and smoothed to best fit cell shape and get rid of single positive pixels still present in
the background. A further step of pixel erosion helped achieve satisfactory cell shape
fitting. To be sure to select only cells entirely present in the acquired field, for CD11b
staining, cells with an area >25 μm2 were analyzed (Figure 2A–A‘’). For CD45 staining,
we only segmented round-shaped CD45high cells, which showed more intense signal
than CD45low cells, by selecting appropriate max constant values. We applied a thresh-
old of area >10 μm2, since the CD45 staining procedure does not use secondary anti-
body and results in lower signal amplification.
Figure 2 Shape descriptor and grid crossing protocols. Shape descriptors (area, perimeter, circularity,
Feret’s diameter, aspect ratio, and solidity) were quantified on 179 × 133 μm fields (A). The original image
was scaled to microns and segmented by applying the Max function on Fiji (A’, see methods). Objects with
> 25 μm2 area were selected and analyzed (A’’, outlines of selected objects for analysis). For the grid
crossing counts, a grid with 9 × 9 μm spaced lines was used (B). This was overimposed to the image (B’)
and intersections between > 25 μm2 objects (previously segmented), and the grid were quantified (B’’).
Scale bar = 20 μm.
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for the following parameters: area, perimeter, Feret’s diameter (caliper), circularity, aspect
ratio, and solidity. Mean single cell values for each parameter were used for statistics.
Segmented objects were also superimposed on a grid image with horizontal and vertical
lines distanced by 9 μm. The total number of object crossing on the grid was quantified
and normalized for the total number of segmented objects (Figure 2B–B‘’).Immunofluorescence and confocal analysis
Immunofluorescence was performed on 20-μm coronal sections according to the previ-
ously described method [18]. Primary antibodies used were anti-mouse CD45 (1:800)
and anti-mouse CD11b (1:500, kindly provided by Dr. Doni). The fluorconjugated sec-
ondary antibody used was Alexa 546 anti-rat (1:500, Invitrogen, Carlsbad, CA). Appro-
priate negative controls without the primary antibodies were performed. None of the
immunofluorescence reactions revealed unspecific fluorescent signal in the negative
controls. Immunofluorescence was acquired using a scanning sequential mode to avoid
bleed-through effects by an IX81 microscope equipped with a confocal scan unit
FV500 with three laser lines: Ar-Kr (488 nm), He-Ne red (646 nm), and He-Ne green
(532 nm, Olympus, Tokyo, Japan) and a UV diode. Three-dimensional images were ac-
quired over a 10-μm z-axis with a 0.23-μm step size and processed using Imaris soft-
ware (Bitplane, Zurich, Switzerland) and Photoshop CS2 (Adobe Systems Europe Ltd).Statistical analysis
Comparisons among groups were done by appropriate analysis of variance and post
hoc test as indicated in each figure legend. Choice of parametric or non-parametric test
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mal distribution. All groups had a normal distribution. Group size was defined by the
following formula: n = 2σ2f(α,β) / Δ2 (sd in groups = σ, type 1 error α = 0.05, type II
error β = 0.2, percentage difference between groups Δ = 30). Standard deviation between
groups was calculated on the basis of a previous experiment for CD11b stained area
quantification, where σ = 19, thus yielding n = 6.34. Statistical analysis was performed
using standard software packages GraphPad Prism (GraphPad Software Inc., San
Diego, CA, USA, version 6.0). All data are presented as mean and standard deviation
(sd). p values lower than 0.05 were considered statistically significant.Results
A typical distribution of the lesion over the anteroposterior coordinates for each model
of injury, namely, tMCAo, pMCAo, and TBI at 24 h is depicted in Figure 1A. The max-
imal extension of the lesioned area was located at −0.88, +0.08, and −1.84 mm from the
bregma for tMCAo, pMCAo, and TBI, respectively. The lesion core corresponded to the
striatum for tMCAo and to the cortex for pMCAo and TBI [8,11,19] (Figure 1B). These
sections were selected for subsequent quantitative immunohistochemical analysis.Activated microglia (CX3CR1+ cells) show a different distribution in the three injury
models 24 h after injury
cx3cr1+/GFP mice express GFP under the control of the promoter for the fractalkine recep-
tor (CX3CR1) that is constitutively present on microglia cell membrane, while it is indu-
cible on macrophage subsets. GFP+ cells were found to be homogeneously distributed all
over the lesion after tMCAo, displaying a hypertrophic morphology (Figure 3A–D). At
variance, GFP+ cells were not detectable in the lesion core after pMCAo (Figure 3H) or
TBI (Figure 3N). Following either pMCAo or TBI, hypertrophic GFP+ cells surrounded
the lesion core (Figure 3I, O). Immunofluorescent stainings and confocal analysis con-
firmed that after tMCAo, GFP+ cells co-localized with ramified, but not round-shaped
CD11b+ cells (Figure 3E), thus confirming that, in the brain parenchyma, at 24 h after in-
jury, GFP is selectively expressed by resident microglia, as shown previously [11]. In line
with this observation, GFP+ cells were negative for CD45high, a marker of infiltrating leu-
kocytes (Figure 3F, [18]). In the lesion core of either pMCAo or TBI, most of the CD11b+
cells had a round-shaped morphology and did not express GFP (Figure 3K, Q). Moreover,
CD45high+ cells present in this area did not express GFP (Figure 3L, R) similarly to what
observed for the tMCAo model.
In the three models, GFP+ cells were present along the border zone of the lesion and
co-localized with ramified, but not with round-shaped CD11b+ cells (Figure 4A, C, E)
or CD45high+ cells (Figure 4B, D, F).Shape parameters for CD11b stained cells indicate a prevalence of ramified cells after
tMCAo compared to either pMCAo or TBI
Area
Area was calculated as the total number of pixels present in a single object and is
expressed in square micrometers (pixel size = 0.172 × 0.172 μm). This area is expected
Figure 3 GFP+ microglia distribution over the lesion area at 24 h after tMCAo, pMCAo, or TBI. GFP+
microglia showed homogenous distribution over the lesioned hemisphere after tMCAo (A). Microglial
hypertrophic morphology was evident both in the cortex (B) and the striatum (lesion core, C). On the
contralateral side GFP+ cells displayed the typical ramified morphology with thin branches (D). Within the
lesion core, GFP (green) co-localized with CD11b (red, pan-marker of microglia/macrophages, E) only in
ramified CD11b+ cells. No co-localization was observed between GFP and round-shaped CD11b+ (E) or
CD45high+ cells (infiltrating leukocytes, F). After pMCAo (G) GFP+ microglia were not present in the lesion
core (H). Hypertrophic GFP+ cells surrounded the lesion and placed at lesion border (I). Normal ramified
morphology was observed in contra-lateral side (J). The lesion core was populated by round-shaped
GFP-/CD11b+ and GFP- /CD45high+ cells (K, L). After TBI (M) GFP+ microglia had similar appearance as to
pMCAo: absent in the lesion core (N), hypertrophic at lesion border (O) and ramified with thin branches in
contra-lateral side (P). The lesion core was populated by round-shaped GFP-/CD11b+ and GFP- /CD45high+
cells (Q, R). Data are representative of 3 independent experiments. Scale bars= 20 μm.
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ing of new ramifications.
The mean area of CD11b+ cells was significantly increased after tMCAo (85.78 ±
14.60, μm2 ± sd) compared to naïve mice (striatum, 54.57 ± 3.33). The mean cell area
after either pMCAo or TBI (57.13 ± 7.24 or 71.90 ± 9.95, respectively) was lower than
that after tMCAo (Figure 5A).
Figure 4 GFP+ (green) co-localization with CD11b or CD45high (both red) in the lesion border area
at 24h after tMCAo, pMCAO, or TBI. In all tMCAo (A), pMCAo (C) and TBI (E), lesion borders were populated
by ramified GFP+/CD11b+ microglia. Notably, neither round-shaped CD11b+ nor CD45high+ cells (B, D, F)
expressed GFP. Data are representative of 3 independent experiments. Scale bars = 20 μm.
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This parameter was calculated based on the outline length of a given object and is
expressed in microns. The perimeter is expected to be higher in activated and rami-
fied cells.
The mean perimeter of CD11b+ cells was significantly increased after tMCAo (75.27 ±
7.56, μm± sd) compared to naïve mice (striatum, 61.46 ± 7.38). The mean cell perimeter
after either pMCAo or TBI (47.69 ± 6.90 or 58.36 ± 8.89, respectively) was lower than that
after tMCAo (Figure 5B).
Circularity)
Circularity was calculated by the following formula: 4π × (area/perimeter2). This param-
eter varies from 0 (linear polygon) to 1 (perfect circular object).
Figure 5 Quantitative analysis of CD11b+ cells 24 h after acute brain injury. Area (A), perimeter (B),
circularity (C), Feret’s diameter (D), aspect ratio (E), and solidity (F) calculated for naïve (striatum and
cortex), tMCAo, pMCAo, or TBI mice are shown as box and whiskers with line at mean and min-to-max
values. One-way ANOVA followed by Tukey’s multiple comparison test, *p < 0.05, **p < 0.01, and ***p < 0.001,
n = 6. The drawings beside the y-axis indicate expected values for each parameter depending on cell shape
(ramified vs. ameboid) (A, B, C, D, F) or cell symmetry (E). Frequency distribution plots for individual cells are
shown. Dotted lines correspond to the value indicated below each line.
Zanier et al. Intensive Care Medicine Experimental  (2015) 3:7 Page 10 of 18CD11b+ cells showed higher circularity after either pMCAo (0.38 ± 0.07) or TBI
(0.37 ± 0.05) compared to naïve mice (0.26 ± 0.02) and to tMCAo (0.25 ± 0.03).
By analyzing the frequency distribution plot (lower panel in Figure 5C), it appears
that these differences were due to a bigger fraction of cells with >0.5 circularity in ei-
ther pMCAo or TBI (Figure 5C).
Feret’s diameter (caliper)
Feret’s diameter represents the longest distance between two parallel lines perpendicu-
lar to that distance and drawn at the object’s boundaries. Thus, it represents the max-
imum caliper diameter obtained assuming that the cell was measured by means of a
caliper. This parameter is expected to increase with cell hypertrophism and new ramifi-
cation elongation.
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to either naïve striatal (17.10 ± 1.35) or pMCAo cells (14.92 ± 1.70). Moreover, pMCAo
had smaller caliper cells compared to TBI (17.73 ± 2.09).
In the frequency distribution plot (lower panel in Figure 5D), the fraction of cells
with >20-μm caliper increased in tMCAo mice (Figure 5D).
Aspect ratio
Aspect ratio is calculated as the ratio between the major and the minor axis of the best fit-
ted ellipse to a given object. This parameter varies with cell morphological polarization,
being higher in elongated cells (Figure 5E).
No statistically significant differences could be detected in this parameter.
Solidity
Solidity is calculated by dividing the area of an object by its convex area. The latter is
the area of the smallest polygon drawn around the object that satisfies two conditions:
1) it is convex (all its interior angles measure less than 180°) and 2) it contains the ori-
ginal region. The more ramified is the object, the bigger is the convex area, thus yield-
ing a smaller solidity (Figure 5F).
CD11b+ cells in either pMCAo or TBI mice displayed higher solidity (0.68 ± 0.04 or
0.65 ± 0.03, respectively) compared to controls (naïve cortex, 0.55 ± 0.03) and to
tMCAo (0.55 ± 0.02).
An increase in the fraction of cells with >0.5 solidity was evident for either pMCAo
or TBI (lower panel in Figure 5F).
Grid crossings
When a grid with 9 μm spaced lines is overimposed to an image of stained cells, the
number of crossing between the stained objects (>25 μm2 area) and the grid can be
calculated (Figure 6A). Total number of crossings is then normalized to the total num-
ber of objects. Ramified objects are expected to have frequent crossings with the grid
(Figure 6B, top panel), while round-shaped ones have few crossings (Figure 6B, bottom
panel). Cells in tMCAo crossed the grid 4.39 ± 0.36 times (mean ± sd), significantly
more frequently than pMCAo (2.66 ± 0.44) or TBI (3.22 ± 0.49) cells.
Shape parameters for CD45high cells had constant values in the three models
The previously reported shape parameters were applied to CD45high+ cells. These are
the round-shaped cells that are recruited to the brain after acute injury [8,11,19] and
that are not prone to change morphology. As expected, none of the shape parameters
tested showed a significant difference in the three injury models (Figure 7A–F). In
naïve mice, we could not detect any CD45high+ cells, consistently with no immune cell
infiltration in unpeturbed brain tissue [18,19].
Grid crossings did not vary among the groups (Figure 7G) and the values were below
1.5 crossing per cell, thus indicating the presence of small round objects (see Figure 6B).
In line with an increased presence of round-shaped cells in pMCAo or TBI (see
Figure 5A, F), these lesions showed an increased infiltration of CD45high+ cells (156.70 ±
58.45 or 240.90 ± 81.82, cells/mm2 ± sd, respectively) compared to tMCAo (50.76 ± 54.38,
Figure 7H).
Figure 6 Grid crossings by CD11b stained cells 24h after acute brain injury. CD11b+ cells in the
lesion core displayed significantly increased grid crossings after tMCAo compared to either pMCAo or TBI
(A). This indicates an increased presence of ramified microglia in tMCAo, since ramified cells are expected
to have more frequent crossings with the grid compared to round-shaped cells (B). Data are shown as box
and whiskers with line at mean and min-to-max values. One-way ANOVA followed by Tukey’s multiple
comparison test, **p<0.01, ***p<0.001, n=6.
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In the present study, we have determined the morphology of brain CD11b cells, defin-
ing specific population subsets present in the injured tissue following different injurious
stimuli. Specifically, we have validated objective parameters associated with morph-
ology, including area, perimeter, Feret’s diameter (caliper), circularity, aspect ratio, so-
lidity, and the number of grid crossings between cell-positive area and a grid.
We used three models of acute brain injury, namely, tMCAo, pMCAo, and TBI, that
share blood perfusion deficits and metabolic derangements as common events, and we
described distinctive morphological features of recruited/activated M/M in the injured
tissue. We showed that the shape descriptors that best represent M/M ramification/
elongation are area and perimeter, while circularity and solidity provide information on
the ameboid shape. We also provided preliminary evidence on the involvement of dif-
ferent populations in local inflammatory events, with macrophages replacing microglia
cells into the lesion core in case of no reperfusion.CX3CR1 (fractalkine receptor) is expressed exclusively by resident microglia in brain
parenchyma 24 h following acute injury
Appropriate discrimination between microglia and macrophages would help define
whether or not these cells, although sharing multiple features [3,28], have selective roles
during neuroinflammation. We here show that the expression of GFP in cx3cr1GFP/+ mice
allows to discriminate between microglia and macrophages at early time points after acute
insult (24 h). In a previous work, we demonstrated that, after tMCAo, GFP is expressed
by ramified resident microglia, while infiltrating immune cells (round-shaped CD11b+,
CD45high+, and CD3+) do not express it [11]. We now extend the same observation to
pMCAo and TBI, both conditions inducing immune cell infiltration and microglia
Figure 7 Quantitative analysis of CD45high+ cells 24 h after acute brain injury. Area (A), perimeter (B),
circularity (C), Feret’s diameter (D), aspect ratio (E), solidity (F), and grid crossings (G) calculated for naïve
(striatum and cortex), tMCAo, pMCAo, or TBI mice are shown as box and whiskers with line at mean and
min-to-max values. None of these parameters changed across models, in line with the unvaried round-
shaped morphology of CD45high+ cells. CD45high+ cell density (H) in the lesion core after pMCAo and TBI
was higher compared to tMCAo. One-way ANOVA followed by Tukey’s multiple comparison test, *p < 0.05,
***p < 0.001, n = 6 (n.d. = not detectable).
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early recruited via the CCR family receptors and do not express CX3CR1 [30-32].Resident microglia are depleted if no reperfusion is allowed
It is generally believed that, once infiltrated in the brain, macrophages populate the same
lesioned areas as microglia. However, the distinct resilience of macrophages and microglia
to ATP loss may cause different distribution of these populations over the lesioned area.
In the case of ischemic/reperfusion injury, both microglia and macrophages are present in
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sion edge, a large area depleted from microglia is consistently detected. In our study,
the microglia-empty territory was replenished by round-shaped CX3CR1−/CD11b+/
CD45high+ cells, which are likely to be the infiltrating macrophage population. After
selective microglia depletion in CD11b-HSVTK mice [33], macrophages engraft
microglia-depleted regions and acquire a microglia-like behavior, extending processes
towards an ATP source and keeping the cerebral homeostasis.
In case of a severe acute injury with impairment of cerebral blood flow (CBF), brain
homeostasis is disrupted and metabolic crisis occurs, leading to massive death of cere-
bral populations, including microglia. In these conditions, macrophages, which can
switch to anaerobic metabolism [17], infiltrate and acquire specific functional pheno-
types that evolve with the lesion progression [19]. A different behavior of macrophages
compared to microglia may be observed, being microglia mostly located at pMCAo or
TBI lesion boundaries, with lower expression of polarization markers [19]. Additional
studies are needed to relate features of microglia and macrophages in acute brain injury
to specific function.CD11b is a reliable marker to study M/M morphology
We selected M/M on the basis of CD11b positivity [19,29]. Due to its presence on the
membrane surface and to its constitutive expression on myeloid cells, CD11b is par-
ticularly suitable to study the morphology of M/M in either physiological or patho-
logical conditions. M/M are often labeled by using other constitutive markers, e.g., Iba1
and CD45, or by isolectin B4 from Griffonia semplicifolia that binds α-D-galactosyl res-
idues. Among these markers, only Iba1 provides information comparable to those ob-
tained with CD11b on M/M activation and morphology [14]. Indeed, CD45 yields a
weak signal in low expressing cells, e.g., microglia, whose identification might be tricky,
so this marker is best used for CD45high+ cell counting [11,18,19], while isolectin B4
shows non-homogeneous labeling of M/M and binds also to endothelial cells [34].M/M morphological features 24 h after injury indicate differential M/M activation and
subtype distribution depending on the kind of injury
CD11b+ cell area and perimeter were higher in tMCAo compared to naïve animals
(striatum), indicating the presence of hypertrophic microglia, as well as to pMCAo and
TBI mice, due to the increased infiltration of CD45high+ cells in these latter models. In-
filtrated macrophages are indeed smaller than hypertrophic microglia and with limited
ability to change morphology, thus explaining the smaller CD11b+ cell size found in
pMCAo or TBI.
Interestingly, CD11b+ cell Feret’s diameter in TBI was bigger than that in pMCAo. In
TBI, most of the lesion core is lost and sampling included wider border areas where
hypertrophic microglia sit. We did not detect significant differences in area, perimeter,
and Feret’s diameter between pMCAo or TBI and naïve cortex. Steady-state microglia
in naïve mice have thin ramifications that, due to the microscope resolution limit, could
have been excluded from the identified objects. Moreover, the bidimensional acquisi-
tion of the images fails to properly include ramifications belonging to different focal
planes. These technical limits could lead to underestimation of area, perimeter, and
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tivity. It should be mentioned that naïve and not sham-operated animals were used in
this study potentially raising the issue on the surgery versus injury effect. In previous
works, we constantly observed M/M activation based on CD11b immunoreactivity, by
comparing each model with proper sham-operated mice, thus confirming an injury ef-
fect and showing negligible impact of the surgical procedure on cortical and striatal M/
M activation ([11] for tMCAo; [19] for pMCAo; unpublished submitted data for TBI).
The focus of the present study was the comparison of M/M morphology in the three
models and we choose an unperturbed condition as a common control group.
A clear-cut difference between pMCAo/TBI and naive animals was obtained measur-
ing circularity and solidity. These parameters yielded similar results and may be consid-
ered as indices of the same morphological feature. CD11b+ cells showed a more
round-shaped morphology in pMCAo and TBI, in line with increased infiltration of
peripheral immune cells.
Aspect ratio was the only parameter not changing across the models. It indicates the
morphological polarization of a given object. The observation that in tMCAo aspect ra-
tio did not change compared to pMCAo, or TBI, suggests that at 24 h CD11b+ cells
were not directed towards a specific site. Directional ramification extension may be
more relevant at earlier time points due to the damage-sensing microglia reorientation.
At 24 h, microglia already show a hypertrophic ameboid morphology characterized by
short and numerous processes, symmetrically extending from the cell soma [11].
Microglia morphology can also be influenced by the cellular architecture of specific
brain areas [35]. The observed symmetric morphology may be due to the sampling of
the gray matter, where microglia extend processes radially [36]. At variance with this,
the white matter is populated by a specific type of microglia with bipolar, elongated
morphology, called rod microglia. Rod microglia are in close association with neurons
[37,38] and take part to axonal damage and recovery after injury [39].The grid crossing method offers a reliable measure of M/M morphology
This technique is usually applied to quantify vascular density [40]. In the context of CD11b+
morphology evaluation, the number of grid crossings can be used to provide information
on ramification density, being ramified cells able to cross the grid more frequently than
round-shaped objects. In line with this, tMCAo mice had increased grid crossings com-
pared to either pMCAo or TBI. This approach may be considered a simplified version of
the Sholl analysis which, based on single cell selection and overimposition to a field formed
by concentric circles with increasing radius, provides quantification of branch length and
frequency [41]. Although accurate and applicable to measure microglia morphology [11],
Sholl analysis requires single cell selection, thus limiting the total number of quantified cells
(small region of interest). The method of grid crossings proposed here can instead be ap-
plied to big image data sets, allowing to obtain measures over wide tissue portions in a lim-
ited time. The sensitivity may be appropriately enhanced by changing the grid dimensions.Validation of the proposed approach
The observation that CD45high+ cells, whose shape is not expected to change, did not
show significant changes in the morphological parameters further confirmed the validity
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count, was different in the three models, as expected. CD45high+ cell density was
greater in pMCAo or TBI compared to tMCAo, in line with increased immune cell in-
filtration in injury models with no reperfusion [42,43] compared with ischemic/reper-
fusion injury [44].
Conclusions
In conclusion, we obtained a full characterization of morphological M/M state, by val-
idating quantitative parameters, over wide injured tissue portions. We showed that only
when reperfusion is there, microglial cells are present in the injured core where they
become activated. At variance with this, when reperfusion is not allowed, microglial
cells populate the area surrounding the lesion core, and this latter is in turn replenished
by infiltrating macrophages. These pieces of information set the line to clarify the func-
tional meaning of M/M activation and potential distinctive features of microglia versus
macrophages in injury resolution and repair.
We provide a sensitive and readily applicable approach for morphological analysis of
stained objects with the intrinsic limitation related to the bidimensional approaches.
We used appropriate size thresholds to exclude small objects not representing entirely
a cell, such as ramification portions from out-of-focus cells, and we distributed acquisi-
tion frames equally by an operator non-dependent sampling of the region of interest,
thus limiting the impact of non-stereological acquisition.
Notably, the (potential) strength of our approach goes beyond the proposed applica-
tion since in principle it can be applied to all cell types able to change shape following
activation, e.g., astrocytes, or to different disease states, including chronic pathologies.
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